Article information
Full text is only aviable in PDF
Bibliografía
[1.]
A.S. Viner, N. Jackman.
Retrospective study of 1,271 patients diagnosed as perennial rhinitics.
Clin Allergy, 6 (1976), pp. 251-259
[2.]
E. Pantorello, C. Ortolani, M.T. Luraghi, V. Pravettoni, V. Sillano, M. Froli, G. Anabile, C. Zanussi.
Evaluation of allergic aetiology in perennial rhinitics.
Ann Allergy, 55 (1985), pp. 854-856
[3.]
R.B. Trang, L.-C. Tsai, H.-M. Hwang, B. Hwang, K.-G. Wu, M.-W. Hung.
The prevalence of allergic disease and IgE antibiotics to house dust mite in school-children in Taiwan.
Clin Exp Allergy, 20 (1990), pp. 33-38
[4.]
R.A. Barbee, M.D. Lebowits, H.C. Thompson, B. Burrows.
Immediate skin test reactivity in a general population sample.
Ann Int Med, 84 (1976), pp. 129-137
[5.]
C. Ortolani, A. Miadonna, R. Adami, M. Restuccia, C. Zanussi.
Correlation of the specific IgE in serum and nasal secretions with clinical symptoms in atopics.
Clin Allergy, 11 (1981), pp. 249-256
[6.]
P.H. Howarth, A. Lunn, S. Tomkins.
Bedding barrier intervention in house dust mite respiratory allergy.
Clin Exp Allergy, 22 (1992), pp. 140
[7.]
S.D. Bowler, C.A. Mitchell, J. Miles.
House dust mite control and asthma: a placebo control trial of cleaning air filtration.
Ann Allergy, 55 (1985), pp. 498-500
[8.]
R.E. Reisman, P.M. Mauriello, G.B. Davis, J.M. Georgitis, J.M. DeMasi.
A double-blind study of the effectiveness of a highefficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma.
J Allergy Clin Immunol, 85 (1990), pp. 1.050-1.057
[9.]
W. Kersten, D. Stollewerk, H. Musken.
Klinische Studie zur Wirksamkeit der akariziden Substanz Acarosan bei Hausstaubmilbenallergiken.
Allergologie, 11 (1988), pp. 371-390
[10.]
H. Morrow Brown, T.G. Merrett.
Effectiveness of an acaricide in management of house dust mite allergy.
Ann Allergy, 67 (1991), pp. 25-31
[11.]
F.M. Kneist, E. Young, M.C.G. Van Praag, H. Vos, H.S.M. Kort, W.J. Koers, F. De Maat-Bleeker, J.E.M.H. Van Bronswijk.
Clinical evaluation of a double-blind dust mite avoidance trial with mite-allergic rhinitic patients.
Clin Exp Allergy, 21 (1991), pp. 39-47
[12.]
K. Bartholome, W. Kissler, H. Baer, E. Kopietz-Schulte, U. Wahn.
Where does cat allergen 1 come from?.
J Allergy Clin Immunol, 76 (1985), pp. 503-506
[13.]
C. Luczynska, Y. Li, M.D. Chapman, T.A.E. Platts-Mills.
Airborne concentrations and particle distribution of allergen derived from domestic cats (Felis domesticus) measurements using a Cascade impactor, liquid impinger and a two site monoclonal antibody assay for Fel dI.
Am Rev Respir Dis, 141 (1990), pp. 361-367
[14.]
K. Leitermann, J.L. Ohman.
Cat allerg Biochemical anfigenic allergenic properties.
J. Allergy Clin Immunol, 74 (1984), pp. 147-153
[15.]
R. Glinert, P. Wilson, H.J. Wedner.
Fel dI is markedly reduced following sequential washing of cats.
J Allergy Clin Immunol, 85 (1990), pp. 225
[16.]
F. de Blay, M.D. Chapman, T.A.E. Platts-Mills.
Airborne cat allergens (Fel dI). Environmental control with the cat in situ.
Am Rev Resp Dis, 143 (1991), pp. 1.334-1.339
[17.]
R. Paganelli, I. Quinti, A. di-Sabatinom, G.P. d-Offizi, E. Scale, P. Meglio, F. Auti.
Topical flunisolide treatment of perennial rhinitis: clinical and immunological effect.
Allergol-Immunopathol, 20 (1992), pp. 124-126
[18.]
M.M.-L. Janssens, G. Vanden Bussche.
Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
Clin Exp Allergy, 21 (1991), pp. 29-36
[19.]
P.H. Howarth.
Allergic rhinitis: a rational choice of treatment.
Respiratory Medicine, 83 (1989), pp. 179-188
[20.]
M. Croft.
Torsades-de-pointes after astemizole overdose.
Br Med J, 292 (1986), pp. 660
[21.]
F.E.R. Simons, M.S. Kesselman, N.G. Giddins, A.N. Pelech, K.J. Simons.
Astemizole induced torsades-de-pointes.
Lancet, 2 (1988), pp. 624
[22.]
B.P. Monahan, C.L. Ferguson, E.S. Killeary, B.K. Lloyd, J. Tray, L.R. Cantilena.
Torsades-de-pointes occurring in association with terfenadine use.
JAMA, 264 (1992), pp. 2.788-2.790
[23.]
M. Zimmerman, H. Duruz, O. Broccand, D. Levy, D. Lacates, A. Bloch.
Torsades-de-pointes after treatment with terfenadine and ketoconazole.
Eur Heart J, 13 (1992), pp. 1.002-1.003
[24.]
S. Pohjola-Sintonen, M. Viitasalo, L. Toivonen, P. Neuronen.
Torsades-de-pointes after terfenadine-itraconazole interaction.
Br Med J, 306 (1993), pp. 186
[25.]
P.K. Honig, R.L. Woosley, K. Zamani, D.P. Conner, L.R. Canilena.
Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.
Clin Pharmacol Ther, 52 (1992), pp. 231-238
[26.]
J.P. Kemp.
Antihistamines -is there anything safe to prescribe.
Annals of Allergy, 169 (1992), pp. 276-280
[27.]
J.E. Stroh, G.H. Ayars, I.L. Bernstein, J.P. Kemp, W.K. Podleski, B.M. Prenner, W.F. Schoenwetter, J.K. Salzmann.
A comparative tolerance study of terfenadine-pseudoephedrine combination tablets and pseudoephedrine tablets in patients with allergic or vasomotor rhinitis.
J Int Med Res, 16 (1988), pp. 420-427
[28.]
W.W. Busse, P.G. Creticos, J. Dolovitch, et al.
Double-blind eastern multicenter trial of levocabastine-D in allergic rhinitis.
J Allergy Clin Immunol, 91 (1993), pp. 194
[29.]
H.R. Knapp.
Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.
New Eng J Med, 323 (1990), pp. 1.745-1.748
[30.]
A. Donnelly, M. Glass, B. Muller, S. Smart, J. Hutson, M.C. Minkwitz, T.B. Casale.
Leukotriene D4 (LTD4) antagonist ICI204, 219 relieves ragweed allergic rhinitis symptoms.
J Allergy Clin Immunol, 91 (1993), pp. 259
[31.]
N. Handelman, G.A. Friday, H.J. Schwartz, et al.
Cromolyn sodium nasal solution in the prophylactic treatment of polleninduced seasonal allergic rhinitis.
J Allergy Clin Immunol, 59 (1977), pp. 237-242
[32.]
H.A. Orgel, E.O. Meltzer, J.P. Kemp, N.K. Osborn, M.J. Welch.
Comparison of intranasal cromolyn sodium, 4% and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance and rhinomanometry.
Ann Allergy, 66 (1991), pp. 237-244
[33.]
D.E. Schuller, J.E. Selcow, T.H. Joos, et al.
A multicentre trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis.
J Allergy Clin Immunol, 86 (1990), pp. 554-561
[34.]
H.M. Druce, S. Goldstein, J. Melamed, J. Grossman, B.A. Moss, R.G. Townley.
Multicentre, placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis.
Ann Allergy, 65 (1990), pp. 212-216
[35.]
R.H. Cohan, F.L. Bloom, R.B. Rhwades, H.J. Wittig, L.D. Haugh.
Treatments of perennial allergic rhinitis with cromolyn sodium.
J Allergy Clin Immunol, 58 (1976), pp. 121-128
[36.]
O. Resta, M.P. Foschino Barbara, N. Carnimeo.
A comparison of sodium cromoglycate nasal solution and powder in the treatment of allergic rhinitis.
Br J Clin Pract, 36 (1982), pp. 94-98
[37.]
P.W. Welsh, W.E. Sticker, M.S. Chu-Pin Chu, et al.
Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy.
Mayo Clin Proc, 62 (1987), pp. 125-134
[38.]
I. Feather, D. Peroni, S. Wilson, S. Smith, P.H. Howarth.
Prophylactic fluticasone propionate aqueous nasal spray (FP) suppresses eosinophil and mast cell accumulation in seasonal allergic rhinitis.
J Allergy Clin Immunol, 91 (1993), pp. 260
[39.]
E. Gómez, T.E. Clague, D. Gatland, R.J. Davies.
Effect of topical corticosteroids on seasonally induced increased in nasal mast cells.
Br Med J, 296 (1988), pp. 1.572-1.573
[40.]
L.M. Klein, R.M. Larker, W.L. Matis, G.F. Murphy.
Degranulation of human mast cells induces an endothelial antigen central to leucocyte adhesion.
Proc Natl Acad Sci, 86 (1989), pp. 8.972-8.976
[41.]
R.P. Schleimer.
Glucocorticosteroids: their mechanism of action and use in allergic diseases. En: Middleton et al., editores.
Allergy principies and practice, Mosby, (1993), pp. 893-925
[42.]
J. Bousquet, F.-B. Michel.
Immunotherapy.
Allergic and non-allergic rhinitis clinical aspects, pp. 137-148
[43.]
V.A. Varney, M. Gaga, V.R. Aber, A.B. Kay, S.R. Durham.
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.
Br Med J, 302 (1991), pp. 265-269
[44.]
G.J. Gleich, E.M. Zimmerman, L.L. Henerson, J.W. Yunginger.
Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six year perspective study.
J Allergy Clin Immunol, 70 (1982), pp. 261-271
[45.]
Z. Peng, R.M. Naclerio, P.S. Norman, N.F. Adkinson.
Quantitative IgE-and IgG-subclass responses during and after long term ragweed immunotherapy.
J Allery Clin Immunol, 89 (1992), pp. 519-529
[46.]
E.F. Juniper, P.A. Kline, E.H. Ramsdale, F.E. Hargreave.
Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis.
J Allergy Clin Immunol, 85 (1990), pp. 606-611
[47.]
L.M. Lichtenstein, K. Ishizaka, P.S. Norman, A.K. Sobotka, B.M. Hill.
IgE antibody measurements in ragweed hayfever. Relationship to clinical severity and the results of immunotherapy.
J Clin Invest, 52 (1973), pp. 472-482
[48.]
D.M. Kemeny, H. Tomioka, A. Tsutsumi, T. Koike, M.H. Lessof, T.H. Lee.
The relationship between anti-IgE auto-antibodies and the IgE response to wasp venom during immunotherapy.
Clin Exp Allergy, 20 (1990), pp. 67-69
[49.]
S. McHugh, P. Ewan.
Reduction in increased serum neutrophil chemotactic activity following effective hyposensitisation in house dust mite allergy.
Clin Exp Allergy, 19 (1989), pp. 327-340
[50.]
H. Otsuka, A. Mezawa, M. Ohnishi, K. Okubo, H. Seki, M. Okuda.
Changes in nasal metachromatic cells during allergen immunotherapy.
Clin Exp Allergy, 21 (1991), pp. 115-120
[51.]
V.A. Varney, M. Jacobson, M. Gaga, A.B. Kay, S.R. Durham.
Effects of grass pollen immunotherapy on cutaneous mast cell sub-types and immediate sensitivity to allergen and histamine [resumen].
Thorax, 47 (1992), pp. 87
[52.]
P.S. Creticos, N. Franklin Adkinson Jr., A. Kagey-Sobotka, D. Proud, H.L. Meier, R.M. Naclerio, L.M. Lichtenstein, P.S. Norman.
Nasal challenge with ragweed in hayfever patients: Effect of immunotherapy.
J Clin Invest, 76 (1985), pp. 2.247-2.253
[53.]
M.J. Furin, P.S. Norman, P.S. Creticos, D. Proud, A. Kagey-Sobotka, L.M. Lichtenstein, R.M. Naclerio.
Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity.
J Allergy Clin Immunol, 88 (1991), pp. 27-32
[54.]
R.E. Rocklin, A.L. Sheffer, D.R. Greineder, K.L. Melmon.
Generation of antigen-specific suppressor cells during allergy desensitisation.
New Engl J Med, 302 (1980), pp. 1.213-1.219
[55.]
W.A. Parker, B.A. Whisman, S.J. Apaliski, M.J. Reid.
The relationships between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis.
J Allergy Clin Immunolol, 84 (1989), pp. 667-677
[56.]
M.M. Pienkowski, P.S. Norman, L.M. Lichtenstein.
Suppression of late-phase skin reactions by immunotherapy with ragweed extract.
J Allergy Clin Immunolol, 76 (1985), pp. 729-734
[57.]
S.R. Durham, V.A. Varney, M.R. Jacobson, R.M. Sudderick, A.B. Kay.
Effect of grass pollen immunotherapy on allergen-induced early and late nasal responses [resumen].
J Allergy Clin Immunolol, 91 (1993), pp. 290
[58.]
A.J. Frew, A.B. Kay.
Relationship between infiltrating CD4+ lymphocytes, activated eosinophils and the magnitude of the allergen-induced late phase cutaneous reaction.
J Immunolol, 141 (1988), pp. 4.158-4.164
[59.]
A.B. Kay, Sun Ying, V. Varney, M. Gaga, S.R. Durham, R. Moqbel, A.J. Wardlaw, Q. Hamid.
Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4. IL-5, and GM-CSF in allergeninduced late-phase cutaneous reactions in atopic subjects.
J Exp Med, 173 (1991), pp. 175-178
[60.]
R.E. O’Hehir, H. Yssel, S. Verma, J.E. de Vries, H. Spits, J.R. Lamb.
Clonal analysis of differential lymphokine production in peptide and superantigen-induced T cell anergy.
Int Immunolol, 3 (1991), pp. 819-826
[61.]
M.D. Chapman.
Use of non stimulatory peptides; a new strategy for immunotherapy?.
J Allergy Clin Immunolol, 88 (1991), pp. 300-302
Copyright © 1994. Sociedad Española de Neumología y Cirugía Torácica
